CardioGen Sciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

CardioGen Sciences General Information

Description

Provider of healthcare services. The company develops gene therapy provisions for orphan inherited arrhythmogenic diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Palo Alto, CA
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioGen Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Sep-2015 00000 Completed Startup
1. Seed Round 01-Dec-2014 00000 00000 00.00 Completed Startup
To view CardioGen Sciences’s complete valuation and funding history, request access »

CardioGen Sciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view CardioGen Sciences’s complete cap table history, request access »

CardioGen Sciences Executive Team (1)

Name Title Board Seat Contact Info
Louis Lange MD Founder
To view CardioGen Sciences’s complete executive team members history, request access »

CardioGen Sciences Board Members (2)

Name Representing Role Since
Edmund Ruffin CardioGen Sciences Board Member 000 0000
Silvia Priori CardioGen Sciences Board Member 000 0000
To view CardioGen Sciences’s complete board members history, request access »

CardioGen Sciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Asset Management Ventures Venture Capital Minority 000 0000 000000 0
To view CardioGen Sciences’s complete investors history, request access »